NCT02264197View on ClinicalTrials.gov

Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

June 30, 1998

Conditions
Healthy
Interventions
DRUG

BIBX 245 CL - fed

DRUG

BIBX 245 CL- fasted

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY